BioSpark Labs Welcomes Artelon

Artelon®, a leader in dynamic biomaterial innovation, is expanding its Manufacturing and Research and Development activities to BioSpark Labs. “This expansion to BioSpark enhances our capability to support rapid commercial growth and opens new opportunities for biomaterial innovation. Furthermore, this location connects us to the world-class facilities and collaborative biotech talent in the Georgia Tech…

Read More

A Letter from GCMI Interim Executive Director Saylan Lukas – GCMI’s Continuing Commitment to Excellence in Medtech Innovation

Medtech and life science innovation is rigorous. It requires high levels of acumen and proficiency in multiple disciplines. It can also be immensely capital intensive. Tiffany Wilson founded Atlanta’s Global Center for Medical Innovation (GCMI) in 2012 to help medtech innovators de-risk their technologies, increasing their odds of successful commercialization and positive patient outcomes within…

Read More

Connecting the Dots: Athens Career Academy Unveils Biotech Track, Shaping Real Futures for High School Students

FOR IMMEDIATE RELEASE–February 22, 2024– Athens, Georgia – The Athens Community Career Academy, part of the Clarke County School District, is ushering in a new era of education and community development with its innovative Biotechnology Track. Designed to meet the changing needs of the workforce in Athens, this program aims to prepare high school students…

Read More

GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement

Atlanta, GA, January 29, 2024 – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that the Company’s Board of Directors has approved a reverse stock split of its issued and outstanding shares of common stock, par value $0.001 per share (the “Common Stock”), at a…

Read More

Aruna Bio Announces FDA Clearance of IND for Lead Program AB126, Enabling the First Exosome to Enter in Human Clinical Trials for a Neurological Indication

January 16, 2024 08:00 ET| Source: Aruna Bio BOSTON and ATHENS, Ga., Jan. 16, 2024 (GLOBE NEWSWIRE) — Aruna Bio, Inc., a pioneer in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of lead program,…

Read More

GeoVax Announces Issuance of Malaria Vaccine Patent

Patent Covers Multiple Component Vaccine for Both Prevention and Treatment Atlanta, GA, January 3, 2024 – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that the U.S. Patent and Trademark Office has issued Patent No. 11,857,611 to GeoVax, pursuant to the Company’s patent application No.…

Read More

Celebrating Evolution and Innovation: Our look back at 2023 and ahead to 2024

The life science industry and its innovations are always advancing, always evolving in a never ending quest to address unmet patient and clinical needs. Industry organizations like Georgia Bio may not experience the frequency of flux – driven in large part by new technologies – as the members and partner entities we serve, but when…

Read More

Gov. Kemp: Medical Device Manufacturer Gerresheimer Expands in Peachtree City

Atlanta, GA – Governor Brian P. Kemp today announced that Gerresheimer, a manufacturer for the pharma and life science industry, will invest more than $88 million in expanding its manufacturing operations in Peachtree City, creating over 200 new jobs for Fayette County. “This project is a prime example of the exciting growth of the life sciences…

Read More